GlassScriptPhysician profile
Muhammad Shakil Aslam
NPI 1023053022
$13,615.30
in general payments reported to CMS, 2019-2025
38 companies · $1,720 in 2025
The $1,720 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,757 · 2020: $173 · 2021: $865 · 2022: $3,715 · 2023: $2,327 · 2024: $3,059 · 2025: $1,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,393 · Travel and Lodging: $1,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,393.16 |
| Travel and Lodging | $1,712.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,805.49 | 2022-2025 | Versacross Access Solution, Watchman Access System, Watchman Flx |
| Edwards Lifesciences Corporation | $2,626.94 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,336.42 | 2021-2023 | Ensite Precision |
| Shockwave Medical, INC | $1,075.32 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $937.67 | 2021-2025 | Symplicity G3, Onyx Frontier, Intellis Adaptivestim |
| Novartis Pharmaceuticals Corporation | $832.54 | 2019-2025 | |
| Abiomed | $620.98 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $225.12 | 2019-2022 | |
| Medtronic Vascular, INC. | $186.90 | 2019-2020 | |
| Medtronic USA, INC. | $162.36 | 2019 | |
| Amgen INC. | $162.36 | 2019-2024 | Repatha |
| Cvrx, INC. | $155.12 | 2024 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $149.12 | 2022-2025 | Verquvo, Capvaxive |
| Inari Medical, INC. | $124.17 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $120.35 | 2021-2023 | Diamondback Coronary |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $117.18 | 2021-2024 | Indigo System |
| Sanofi-Aventis U.S. LLC | $113.31 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.70 | 2019-2025 | Lifevest |
| Cardiva Medical, INC. | $109.24 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $102.61 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $69.86 | 2019-2023 | Farxiga, Andexxa |
| Laborie Medical Technologies Corp. | $66.82 | 2024 | Urgent PC Neuromodulation System |
| Philips North America LLC | $50.11 | 2025 | IV Other |
| Actelion Pharmaceuticals US, INC. | $39.70 | 2022-2023 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.40 | 2021-2022 | |
| United Therapeutics Corporation | $32.17 | 2023 | Tyvaso |
| Chiesi USA, INC. | $28.17 | 2023 | Cleviprex, Kengreal |
| Vifor Pharma, INC. | $24.32 | 2019 | |
| Amryt Pharma Holdings LTD | $23.92 | 2021 | |
| Novo Nordisk INC | $23.13 | 2023 | Ozempic |
| Kiniksa Pharmaceuticals International, Plc | $22.38 | 2024 | Arcalyst |
| Tempus Ai, INC | $20.42 | 2025 | Xt Cdx |
| Cordis US Corp. | $19.49 | 2023 | Mynxgrip |
| Bridgebio Pharma, INC. | $19.39 | 2025 | Attruby |
| Ekos Corporation | $17.26 | 2019 | |
| Getinge USA Sales, LLC | $15.54 | 2023 | Cardiosave Hybrid, Type B Plug |
| Elutia, INC. | $15.43 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Aslam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.